🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiaotian Xu

Guilin Medical University

ORCID: 0000-0003-3862-1630

Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and PharmaceuticsMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia”.

Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia

Fluids and Barriers of the CNS(2025)10.1186/s12987-025-00665-6

N/A

0.345DataRank · unranked

9 citations

T.T. Nguyen, Langni Liu, Xiaotian Xu, Amol A. Kulkarni, Jianxiong Jiang +3 more

The TDP43 CFTS Affect Brain Endothelial Cell Functions by Regulating YAP and Tight Junction Proteins in Cerebral Ischemic Injury.

Research Square(2021)10.21203/rs.3.rs-762288/v1

N/A

0.165DataRank · unranked

2 citations

Changwen Zhang, Jianxiong Jiang, Mei Xin, Jiukuan Hao, Xiaotian Xu

Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia

Research Square(2024)10.21203/rs.3.rs-5611378/v1

N/A

0DataRank · unranked

2 citations

T.T. Nguyen, Langni Liu, Xiaotian Xu, Amol A. Kulkarni, Jianxiong Jiang +3 more